Smart Device-based Cardiac Rehabilitation After Myocardial Intervention

Last updated: October 5, 2023
Sponsor: Charles University, Czech Republic
Overall Status: Completed

Phase

N/A

Condition

Hypercholesterolemia

Blood Clots

Occlusions

Treatment

Smart device-based cardiac rehabilitation

Clinical Study ID

NCT03926312
SmartRehab
  • Ages 18-99
  • All Genders

Study Summary

The aim of this study is to evaluate the influence of cardiac rehabilitation based on smart band use and telemonitoring on functional capacity change and risk factors control among patients hospitalized for acute myocardial infarction.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Signed informed consent with the study
  2. Men and women >18 years of age
  3. Patients ≥1 and ≤6 months after type I myocardial infarction
  4. Physical inactivity before MI defined as the absence of moderate to vigorous exercisefor at least 30 minutes 5 or more days a week

Exclusion

Exclusion Criteria:

  1. Heart failure NYHA IIIB-IV
  2. Planned coronary revascularization
  3. Planned major surgery within the next 12 months
  4. Inability to walk for any reason
  5. Comorbidities that would preclude adherence to the rehabilitation program (e.g.arthrosis, active malignancy, major depression or other significant psychiatricdisorder, cognitive impairment) - at the discretion of the physician
  6. Life expectancy less than 12 months
  7. Pregnancy
  8. Inability to operate the smart-watch

Study Design

Total Participants: 64
Treatment Group(s): 1
Primary Treatment: Smart device-based cardiac rehabilitation
Phase:
Study Start date:
June 19, 2019
Estimated Completion Date:
October 05, 2023

Connect with a study center

  • Institute for Clinical and Experimental Medicine

    Prague, CZEC 14021
    Czechia

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.